Surufatinib
- Generic Name
- Surufatinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H28N6O3S
- CAS Number
- 1308672-74-3
- Unique Ingredient Identifier
- B2K5L1L8S9
- Background
Surufatinib is under investigation in clinical trial NCT02588170 (Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors).
- Indication
单药用于治疗无法手术切除的局部晚期或转移性、进展期非功能性、分化良好（G1、G2）的胰腺和非胰腺来源的神经内分泌瘤（pNETs）。
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath